AEON Biopharma (AEON)

• Market cap: $13.4M
• 1 day: -5.83%
• 5 days: 27.63%
• 1 month: 11.49%
• 3 months: 29.68%
• 6 months: 26.83%
• Year to date: -97.55%
• 1 year: -97.93%
• 5 years: -99.86%
• 10 years: -99.86%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5